TABLE 4.
Disease-specific survival Multivariate analysis | Combined recurrence Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
P value | HR (if P < .10) | 95% CI | P value | HR (if P < .10) | 95% CI | ||
Age, per 5 y | .0002 | 1.16 | 1.07–1.25 | Grade combined | .0059 | ||
Grade combined | .023 | Low-grade vs unspecified | 0.71 | 0.32–1.62 | |||
Low-grade vs unspecified | 1.26 | 0.35–4.57 | High-grade vs low-grade | 2.29 | 1.34–3.92 | ||
High-grade vs low-grade | 3.05 | 1.02–9.09 | High-grade vs unspecified | 1.64 | 0.83–3.25 | ||
High-grade vs unspecified | 2.42 | 1.07–5.49 | |||||
Distant recurrence | <.0001 | 2.94 | 1.90–4.57 | ||||
Local recurrence | .0003 | 2.24 | 1.44–3.48 |
Note: Age, sex, race, functional status, tumor size, histology, final margin status, histologic grade, node positivity, local recurrence, distant recurrence, other organ involvement on pathology, tumor rupture, (neo)adjuvant chemotherapy, (neo)adjuvant radiotherapy were included in the univariate. Abbreviations: CI, confidence interval; HR, hazard ratio.